iSpecimen
ISPC
6 hedge funds and large institutions have $183K invested in iSpecimen in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 9 closing their positions.
77% more capital invested
Capital invested by funds: $103K → $183K (+$79.7K)
0.14% more ownership
Funds ownership: 0% → 0.15% (+0.14%)
45% less funds holding
Funds holding: 11 → 6 (-5)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$113K |
| 2 |
FIA
FNY Investment Advisers
New York
|
+$62.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$8.04K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.3K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$217 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$14K |
| 2 |
VF
Virtu Financial
New York
|
-$13K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$11.9K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.1K |
| 5 |
GC
Grimes & Company
Westborough,
Massachusetts
|
-$9.52K |
ISPC Hedge Fund Activity: Q3 2024 in Review
6 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q3 2024, worth a combined $183K — up 77% from $103K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ISPC and 4 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Jane Street, adding an estimated $113K. The largest seller was HRT Financial, exiting entirely with an estimated $14K sold.
- 6 institutional investors held iSpecimen (ISPC) as of Q3 2024, down from 11 in Q2 2024.
- Funds reported $183K of iSpecimen stock for Q3 2024, up 77% quarter-over-quarter.
- 4 funds opened new iSpecimen positions in Q3 2024 and 9 closed out, a net change of -5 holders.
- The largest iSpecimen buyer in Q3 2024 was Jane Street, an estimated $113K added.
- The largest iSpecimen seller in Q3 2024 was HRT Financial, an estimated $14K sold.
Based on aggregated 13F filings for Q3 2024.